Q Linea AB logo

QLINEA - Q Linea AB Share Price

SEK131.5 -6.5  -4.7%

Last Trade - 12:30pm

Sector
Healthcare
Size
Small Cap
Market Cap £331.6m
Enterprise Value £299.3m
Revenue £25.1k
Position in Universe 503rd / 1789
Bullish
Bearish
Unlock QLINEA Revenue
Momentum
Relative Strength (%)
1m -0.55%
3m
6m
1yr
Volume Change (%)
10d / 3m
Price vs... (%)
52w High -26.4%
50d MA
200d MA
Growth & Value
12m Forecast Rolling Industry Market
Valuation (ttm) Industry Market
Margin of Safety
Qualifying GuruScreens
Financial Summary
Year End 31st Dec 2014 2015 2016 2017 2018 2019 2020E 2021E CAGR / Avg
0.000 0.000 0.000 1.50 1.07 1.01 6.00 112.5 -18.1%
PEG
Profitability
ROA
%
%
Cashflow
Dividends
Balance Sheet
NFA
m
FINANCIAL BRIEF: : For the six months ended 30 June 2020, Q linea ABrevenues decreased 75% to SEK243K. Net loss increased 41%to SEK113.4M. Revenues reflect a decrease in demand for theCompany's products and services due to unfavorable marketconditions. Higher net loss reflects Labor & RelatedExpenses in SGA increase of 37% to SEK44.1M (expense),Other External Expenses -Third Parties increase of 33% toSEK47.3M (expense).
Health Trend(F-Score)
0 1 2 3 4 5 6 7 8 9
Bankruptcy Score(Z-Score)
Distress
Cautious
Safe
Earnings Manipulation Risk(M-Score)
Other Ratios
Recent History
Latest interim period vs. prior period Industry Market
3yr Compound Annual Growth Rate Industry Market
Latest News & Insights for QLINEA
Graphical History

Revenue

QLINEA Revenue Unlock QLINEA Revenue

Net Income

QLINEA Net Income Unlock QLINEA Revenue

Normalised EPS

QLINEA Normalised EPS Unlock QLINEA Revenue

PE Ratio Range

QLINEA PE Ratio Range Unlock QLINEA Revenue

Dividend Yield Range

QLINEA Dividend Yield Range Unlock QLINEA Revenue
Analyst Forecasts
Price Target:
( below Price)
31st Dec 2020
31st Dec 2021
Est. Long Term Growth Rate: Net Profit
()
EPS
()
DPS
()
Net Profit
()
EPS
()
DPS
()
Consensus Estimate
1m Change
3m Change
Analyst Consensus
Strong Sell Sell Hold Buy Strong Buy
EPS 2019 /  2020
QLINEA EPS Forecasts Unlock QLINEA Revenue
Profile Summary

Q linea AB is a Sweden-based medical technology company. The Company develops and manufactures in-vitro diagnostic (IVD) solutions for infectious diseases. The Company's core product candidate is ASTar, a fully-automated instrument for Antibiotic Susceptibility Testing (AST). It measures bacteria's antimicrobial susceptibility using the disposables developed by the Company. It is able to provide a susceptibility profile within three to six hours directly from a positive blood culture, which enables early administration of antibiotics specifically targeting the disease-causing pathogen. Its main application is the identification of sepsis in hospital patients and the product is aimed primarily at hospital laboratories.

Directors
Last Annual December 31st, 2019
Last Interim June 30th, 2020
Public Since December 7, 2018
No. of Shareholders: n/a
No. of Employees: 86
Sector Healthcare
Industry Biotechnology & Medical Research
Index
Exchange OMX Nordic Exchange Stockholm
Shares in Issue 27,337,947
Free Float (0.0%)
Eligible for
ISAs
SIPPs
QLINEA Share Price Performance
Share Price
Bid - Ask
Low - High
Spread
Day's Change
Avg Volume
Open - Close
Range (12m)
Beta
Latest News for QLINEA
Upcoming Events for QLINEA
Frequently Asked Questions for Q linea AB
What is the Q linea AB share price?

As of 12:30pm, shares in Q linea AB are trading at SEK131.5, giving the company a market capitalisation of £331.6m. This share price information is delayed by 15 minutes.

How has the Q linea AB share price performed this year?

Shares in Q linea AB are currently trading at SEK131.5 and the price has moved by 0.146k% over the past 365 days. In terms of relative price strength - which takes into account the overall market trend - the Q linea AB price has moved by 0.179k% over the past year.

What are the analyst and broker recommendations for Q linea AB?

Of the analysts with advisory recommendations for Q linea AB, there are there are currently 0 "buy" , 0 "hold" and 0 "sell" recommendations. The overall consensus recommendation for Q linea AB is Buy. You can view the full broker recommendation list by unlocking its StockReport.

When will Q linea AB next release its financial results?

Q linea AB is scheduled to issue upcoming financial results on the following dates:

Interim results are scheduled for: 2021-06-30
What is the Q linea AB dividend yield?

Q linea AB does not currently pay a dividend.

Does Q linea AB pay a dividend?

Q linea AB does not currently pay a dividend.

When does Q linea AB next pay dividends?

Q linea AB does not currently pay a dividend.

How do I buy Q linea AB shares?

To buy shares in Q linea AB you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.

What is the market cap of Q linea AB?

Shares in Q linea AB are currently trading at SEK131.5, giving the company a market capitalisation of £331.6m.

Where are Q linea AB shares listed? Where are Q linea AB shares listed?

Here are the trading details for Q linea AB:

Country of listing: Sweden
Exchange: STO
Ticker Symbol: QLINEA
What kind of share is Q linea AB?

Based on an overall assessment of its quality, value and momentum, Q linea AB is currently classified as a Momentum Trap. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.

Is there a Q linea AB share price forecast 2020?

Shares in Q linea AB are currently priced at SEK131.5. At that level they are trading at 3.86% discount to the analyst consensus target price of 0.00.

Analysts covering Q linea AB currently have a consensus Earnings Per Share (EPS) forecast of -8.55 for the next financial year.

How can I tell whether the Q linea AB share price will go up?

An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Q linea AB. Over the past six months, the relative strength of its shares against the market has been 0.108k%. At the current price of SEK131.5, shares in Q linea AB are trading at 54.27% against their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.

What is the Q linea AB PE Ratio?

We were not able to find PE ratio data for Q linea AB.

Who are the key directors of Q linea AB?

Q linea AB's management team is headed by:

Jonas Jarvius - CEO
Mats Gullberg - VPR
Anders Lundin - CFO
Nils Kristensen - COO
Charlotta Goransson - DMK
Jonas Melin - OTH
Karl Skold - OTH
Erika Kjellberg Eriksson - CHM
Marianne Hansson - IND
Hans Johansson - IND
Ulf Landegren - DRC
Mats Nilsson - DRC
Marcus Storch - DRC
Tiziana Di Martino - OTH
Thomas Fritz - OTH
Who are the major shareholders of Q linea AB?

Here are the top five shareholders of Q linea AB based on the size of their shareholding:

Nexttobe AB Venture Capital
Percentage owned: 35.85% (9.80m shares)
Investment AB Öresund Investment Advisor
Percentage owned: 9.3% (2.54m shares)
Fjärde AP-Fonden Pension Fund
Percentage owned: 7.92% (2.17m shares)
Swedbank Robur Fonder AB Investment Advisor/Hedge Fund
Percentage owned: 7.45% (2.04m shares)
Swedbank Robur Smabolagsfond Sverige Mutual Fund
Percentage owned: 7.19% (1.97m shares)
Similar to QLINEA
© Stockopedia 2020, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.